{
  "title": "No-Action Letter: Salix Pharmaceuticals, Ltd.",
  "link": "https://www.sec.gov/divisions/corpfin/cf-noaction/2019/salix-pharmaceutical-040419-506d.pdf",
  "description": "Securities Act of 1933 Rules 506(d) and 262(b)",
  "guid": "salix-pharmaceutical-040419-506d",
  "category": "No-Action Letter",
  "pubDate": "Fri, 05 Apr 2019 15:45 EDT"
}